EVH
Work Here?
Overview
About EVH
Simplify's Rating
Why EVH is rated
B-
Rated B on Competitive Edge
Rated A on Growth Potential
Rated D+ on Differentiation
Industries
Consulting
Design
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
N/A
Founded
N/A
Simplify's Take
What believers are saying
- Q2 2026 revenue hit $652.5 million, up 46.9%, and guidance rose to $2.6-$2.7 billion.
- Highmark Performance Suite revenue reached $485 million in Q2 2026, up 50% sequentially.
- A new oncology partnership launches by December 2026, targeting $300 million annualized revenue.
What critics are saying
- MER rose to 95% in Q2 2026, crushing margin from Highmark launch costs.
- Evolent ended Q2 2026 with $808.3 million net debt and 2029 maturities.
- Managed-care clients still in-house utilization work; a large contract loss becomes existential.
What makes EVH unique
- Evolent Health’s Highmark oncology review launched May 1, 2026 across four states.
- Its Performance Suite pairs utilization management with enhanced contractual protections and pathway tools.
- Evolent served 6,715 Performance Suite lives in Q2 2026, proving operating scale.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
EVH is Hiring for 2 Jobs on Simplify!
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →
About EVH
Simplify's Rating
Why EVH is rated
B-
Rated B on Competitive Edge
Rated A on Growth Potential
Rated D+ on Differentiation
Industries
Consulting
Design
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
N/A
Founded
N/A
EVH is Hiring for 2 Jobs on Simplify!
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →